Iradimed (IRMD) Net Cash Flow Growth (3y) (2016 - 2026)
Iradimed (IRMD) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 269.22% |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | -3.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.87% |
| Mar 31, 2026 | 32.83% |
| Dec 31, 2025 | -62.18% |
| Sep 30, 2025 | 0.92% |
| Jun 30, 2025 | 15.91% |
| Mar 31, 2025 | 45.18% |
| Dec 31, 2024 | -47.93% |
| Sep 30, 2024 | -0.27% |
| Jun 30, 2024 | -7.87% |
| Mar 31, 2024 | -102.67% |
| Dec 31, 2023 | 6.20% |
| Sep 30, 2023 | -23.89% |
| Jun 30, 2023 | 54.78% |
| Mar 31, 2023 | -147.45% |
| Dec 31, 2022 | -21.22% |
| Sep 30, 2022 | -17.94% |
| Jun 30, 2022 | -14.50% |
| Mar 31, 2022 | -107.80% |
| Dec 31, 2021 | -5.72% |
| Sep 30, 2021 | 10.69% |